Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Acquisition of GB virus type C and lower mortality in patients with advanced HIV disease.

Vahidnia F, Petersen M, Stapleton JT, Rutherford GW, Busch M, Custer B.

Clin Infect Dis. 2012 Oct;55(7):1012-9. doi: 10.1093/cid/cis589. Epub 2012 Jul 2.

2.

Transmission of GB virus type C via transfusion in a cohort of HIV-infected patients.

Vahidnia F, Petersen M, Rutherford G, Busch M, Assmann S, Stapleton JT, Custer B.

J Infect Dis. 2012 May 1;205(9):1436-42. doi: 10.1093/infdis/jis209. Epub 2012 Mar 20.

3.

GBV-C viremia and clinical events in advanced HIV infection.

Sahni H, Kirkwood K, Kyriakides TC, Stapleton J, Brown ST, Holodniy M; OPTIMA Study Team.

J Med Virol. 2014 Mar;86(3):426-32. doi: 10.1002/jmv.23845. Epub 2013 Nov 19.

PMID:
24249700
4.

Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.

Sheng WH, Hung CC, Wu RJ, Wang JT, Chen PJ, Chang SC, Kao JH.

Clin Infect Dis. 2007 Feb 15;44(4):584-90. Epub 2007 Jan 17.

PMID:
17243064
5.

Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection.

Supapol WB, Remis RS, Raboud J, Millson M, Tappero J, Kaul R, Kulkarni P, McConnell MS, Mock PA, Culnane M, McNicholl J, Roongpisuthipong A, Chotpitayasunondh T, Shaffer N, Butera S.

J Infect Dis. 2008 May 15;197(10):1369-77. doi: 10.1086/587488.

PMID:
18419578
6.

Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals.

Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, Morsica G, Pizzaferri P, Ladisa N, Sighinolfi L, Chiodera A, Solmone M, Lalle E, Ippolito G, Monforte Ad; HepaICoNA Study Group; ICoNA Study Group.

Antivir Ther. 2005;10(1):109-17.

PMID:
15751768
7.

GB virus C infection in children with perinatal human immunodeficiency virus infection.

Schuval S, Lindsey JC, Stapleton JT, Van Dyke RB, Palumbo P, Mofenson LM, Oleske JM, Cervia J, Kovacs A, Dankner WN, Smith E, Nowak B, Ciupak G, Webb N, Eagle M, Smith D, Hennessey R, Goodman-Kerkau M, Klinzman D, Hess G, Zdunek D, Levin MJ; Pediatric AIDS Clinical Trials Group Protocol 1028S Team.

Pediatr Infect Dis J. 2005 May;24(5):417-22.

PMID:
15876940
8.

Frequency and genotype of GB virus C among Iranian patients infected with HIV.

Hekmat S, Mohraz M, Vahabpour R, Jam S, Bahramali G, Banifazl M, Aghakhani A, Eslamifar A, Mahboudi F, Edalat R, Ramezani A.

J Med Virol. 2008 Nov;80(11):1941-6. doi: 10.1002/jmv.21314.

PMID:
18814233
9.

Prevalence and distribution of the GBV-C/HGV among HIV-1-infected patients under anti-retroviral therapy.

Alcalde R, Nishiya A, Casseb J, Inocêncio L, Fonseca LA, Duarte AJ.

Virus Res. 2010 Aug;151(2):148-52. doi: 10.1016/j.virusres.2010.04.008. Epub 2010 Apr 24.

PMID:
20420864
10.

Prevalence of GB virus type C in urban Americans infected with human immunodeficiency virus type 1.

Smith SM, Donio MJ, Singh M, Fallon JP, Jitendranath L, Chkrebtii N, Slim J, Finkel D, Perez G.

Retrovirology. 2005 May 31;2:38.

11.

GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T-cells.

Schwarze-Zander C, Neibecker M, Othman S, Tural C, Clotet B, Blackard JT, Kupfer B, Luechters G, Chung RT, Rockstroh JK, Spengler U.

Antivir Ther. 2010;15(5):745-52. doi: 10.3851/IMP1602.

12.

No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy.

Brumme ZL, Chan KJ, Dong WW, Mo T, Wynhoven B, Hogg RS, Montaner JS, O'Shaughnessy MV, Harrigan PR.

AIDS. 2002 Sep 27;16(14):1929-33.

PMID:
12351953
13.

Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: a meta-analysis.

Zhang W, Chaloner K, Tillmann HL, Williams CF, Stapleton JT.

HIV Med. 2006 Apr;7(3):173-80.

14.

Prevalence of GB virus type C viraemia in MSM with or without HIV-1 infection in Beijing, China.

Liu Z, Li L, Chen Z, Xu M, Zhang T, Jiao Y, Sheng B, Chen D, Wu H.

Epidemiol Infect. 2012 Dec;140(12):2199-209. doi: 10.1017/S0950268812000027. Epub 2012 Mar 26.

PMID:
22444912
15.

Infection with GB virus C and reduced mortality among HIV-infected patients.

Tillmann HL, Heiken H, Knapik-Botor A, Heringlake S, Ockenga J, Wilber JC, Goergen B, Detmer J, McMorrow M, Stoll M, Schmidt RE, Manns MP.

N Engl J Med. 2001 Sep 6;345(10):715-24.

16.

Characterization of GBV-C infection in HIV-1 infected patients.

Canducci F, Uberti Foppa C, Boeri E, Racca S, Gallotta G, Grasso MA, Calori G, Lazzarin A, Clementi M.

J Biol Regul Homeost Agents. 2003 Apr-Jun;17(2):191-4.

PMID:
14518722
17.

GB virus-C infection in patients infected with the human immunodeficiency virus.

Tillmann HL, Manns MP.

Antiviral Res. 2001 Nov;52(2):83-90. Review.

PMID:
11672817
18.

Downregulation of Cytokines and Chemokines by GB Virus C After Transmission Via Blood Transfusion in HIV-Positive Blood Recipients.

Lanteri MC, Vahidnia F, Tan S, Stapleton JT, Norris PJ, Heitman J, Deng X, Keating SM, Brambilla D, Busch MP, Custer B; NHLBI REDS III Study.

J Infect Dis. 2015 May 15;211(10):1585-96. doi: 10.1093/infdis/jiu660. Epub 2014 Nov 25.

19.

Impact of GB virus C viraemia on clinical outcome in HIV-1-infected patients: a 20-year follow-up study.

Ernst D, Greer M, Akmatova R, Pischke S, Wedemeyer H, Heiken H, Tillmann HL, Schmidt RE, Stoll M.

HIV Med. 2014 Apr;15(4):245-50. doi: 10.1111/hiv.12094. Epub 2013 Oct 7.

20.

Effect of coinfection with GB virus C on survival among patients with HIV infection.

Xiang J, W√ľnschmann S, Diekema DJ, Klinzman D, Patrick KD, George SL, Stapleton JT.

N Engl J Med. 2001 Sep 6;345(10):707-14.

Supplemental Content

Support Center